12 completed. 7 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 7 |
| Phase 4 | 2 | Completed 2 |
Follow Rehab Werida: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling Sacubitril/Valsartan 49 MG-51 MG Oral Tablet [ENTRESTO], Empagliflozin10Mg Tab - Heart Failure | Not applicable | Completed | Rehab Werida | 180 | 2025-01-01 | 2026-06-02 |
| BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation BEAM Protocol, CEM protocol - Lymphoma | Not applicable | Completed | Rehab Werida | 58 | 2022-11-11 | 2024-09-05 |
| Early Targeted Antibiotic Therapy in Patients With Sepsis targeted antibiotics therapy - Sepsis | Not applicable | Completed | Rehab Werida | 48 | 2022-05-01 | 2023-09-28 |
| Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD) Dapagliflozin 10mg Tab, Placebo - Nonalcoholic Fatty Liver Disease, Type 2 Diabetes | Phase 4 | Completed | Rehab Werida | 50 | 2022-05-01 | 2025-02-04 |
| Pharmacogenetic Study in Hepatocellular Carcinoma Patients. Doxorubicin, Lipiodol - Hepatocellular Carcinoma | Completed | Rehab Werida | 107 | 2022-01-01 | 2023-07-28 | |
| Infliximab and Adalimumab in Inflammatory Bowel Disease Patients. Infliximab, Adalimumab - Inflammatory Bowel Diseases | Not applicable | Completed | Rehab Werida | 56 | 2022-01-01 | 2024-03-28 |
| Propofol or Sevoflurane Anesthesia in Egyptian Patients Propofol, Sevoflurane - Anesthesia | Not applicable | Completed | Rehab Werida | 44 | 2021-12-01 | 2024-06-04 |
| Pharmacogenetic of Doxorubicin in HCC. Doxorubicin - Hepatocellular Carcinoma | Completed | Rehab Werida | 81 | 2021-01-01 | 2024-03-28 | |
| Fenofibrate Versus Curcumin in Type 2 Diabetic Patients Glimepiride Tablets, glimepiride plus fenofibrate, glimepiride plus curcumin - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Rehab Werida | 60 | 2020-11-01 | 2022-03-04 |
| Alpha Lipoic Acid Against Cardiovascular Events in Patients With Haemodialysis Alpha-Lipoic acid plus renal replacement therapy, renal replacement therapy - Hemodialysis Complication | Not applicable | Completed | Rehab Werida | 36 | 2019-04-11 | 2019-12-26 |
| Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin Rosuvastatin10 mg tablet, Placebo Oral Tablet - Diabetes Mellitus, Type 2 | Not applicable | Completed | Rehab Werida | 70 | 2019-04-01 | 2023-04-14 |
| Circulating IL-6, Clusterin and Irisin in Obese Subjects IL-6, Clusterin, Irisin Level - Obesity | Completed | Rehab Werida | 176 | 2018-02-01 | 2019-10-22 |
Diabetes Mellitus, Type 2 (3) · Carcinoma, Hepatocellular (2) · Heart Failure (1) · Inflammatory Bowel Diseases (1) · Lymphoma (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Sepsis (1)
Doxorubicin (2) · glimepiride (2) · Adalimumab (1) · BEAM protocol (1) · Bendamustine Hydrochloride (1) · Carboplatin (1) · Curcumin (1) · Cytarabine (1) · Ethiodized Oil (1) · Etoposide (1) · Fenofibrate (1) · Genotype (1) · Infliximab (1) · Melphalan (1) · Metformin (1)
Egypt (10) · Saudi Arabia (2)
Rehab H Werida, Ass Prof. (4) · Rehab H Werida, Ass.Prof. (2) · Abdalrhman H Alanizi (1) · Ahmad Salahuddin, Ph.D (1) · Ahmed Shaat, Ph.D. (1) · Amira B. Kassem, Lecturer (1) · Amira Kassem, Ph.D (1) · Eman Momtaz (1) · Eman Nada, B. Pharm (1) · Haidy Abass, Ass.Prof. (1) · Heba Elwan (1) · Lamiaa Khedr, Ass Prof. (1) · Mahmoud Abdallah, Ph.D. (1) · Mohamed Khalef, Ph.D (1) · Mohammad A. Alshabeeb (1)
PMID 23707905, PMID 23723111, PMID 24023786, PMID 26076476, PMID 26105582, PMID 26914659, PMID 28735818, PMID 30150889, PMID 31013312, PMID 31768064, PMID 32274170, PMID 3334893, PMID 38985232, PMID 39134959, PMID 39138591, PMID 40405401, PMID 40481568